Markus Fridén

2.4k total citations
40 papers, 1.7k citations indexed

About

Markus Fridén is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Markus Fridén has authored 40 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 13 papers in Oncology. Recurrent topics in Markus Fridén's work include Inhalation and Respiratory Drug Delivery (17 papers), Drug Transport and Resistance Mechanisms (13 papers) and Asthma and respiratory diseases (12 papers). Markus Fridén is often cited by papers focused on Inhalation and Respiratory Drug Delivery (17 papers), Drug Transport and Resistance Mechanisms (13 papers) and Asthma and respiratory diseases (12 papers). Markus Fridén collaborates with scholars based in Sweden, United Kingdom and Finland. Markus Fridén's co-authors include Margareta Hammarlund‐Udenaes, Ulf Bredberg, Stina Syvänen, Anubha Gupta, Madeleine Antonsson, Hong Wan, Susanne Winiwarter, Brian Middleton, Irena Loryan and Ola Bengtsson and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Markus Fridén

38 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Fridén Sweden 20 772 442 353 287 282 40 1.7k
Andreas Reichel Germany 25 755 1.0× 738 1.7× 243 0.7× 205 0.7× 134 0.5× 88 2.6k
Bill J. Smith United States 20 697 0.9× 467 1.1× 327 0.9× 185 0.6× 91 0.3× 28 1.6k
Tristan S. Maurer United States 29 1.1k 1.4× 908 2.1× 443 1.3× 282 1.0× 102 0.4× 64 2.9k
Ulf Bredberg Sweden 21 621 0.8× 454 1.0× 267 0.8× 200 0.7× 42 0.1× 33 1.9k
J. Cory Kalvass United States 22 1.2k 1.5× 445 1.0× 651 1.8× 253 0.9× 44 0.2× 34 1.9k
Michel Lemaire Japan 28 952 1.2× 619 1.4× 699 2.0× 185 0.6× 122 0.4× 62 2.4k
Italo Poggesi Italy 26 692 0.9× 846 1.9× 140 0.4× 147 0.5× 286 1.0× 114 2.6k
Yanping Sun China 23 516 0.7× 932 2.1× 106 0.3× 87 0.3× 128 0.5× 114 2.6k
Takashi Kuwabara Japan 22 803 1.0× 883 2.0× 79 0.2× 222 0.8× 133 0.5× 56 2.2k
Bo Feng United States 31 2.1k 2.7× 744 1.7× 1.1k 3.3× 191 0.7× 76 0.3× 64 3.4k

Countries citing papers authored by Markus Fridén

Since Specialization
Citations

This map shows the geographic impact of Markus Fridén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Fridén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Fridén more than expected).

Fields of papers citing papers by Markus Fridén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Fridén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Fridén. The network helps show where Markus Fridén may publish in the future.

Co-authorship network of co-authors of Markus Fridén

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Fridén. A scholar is included among the top collaborators of Markus Fridén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Fridén. Markus Fridén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jansson‐Löfmark, Rasmus, Markus Fridén, Lassina Badolo, et al.. (2025). Translational PK/PD: a retrospective analysis of performance and impact from a drug portfolio. Drug Discovery Today. 30(7). 104417–104417.
2.
Gracin, Sandra, Donatienne Tyteca, Francine Uwambayinema, et al.. (2024). Impact of protein aggregation on the immunogenicity of a human monoclonal antibody following pulmonary administration in mice. International Journal of Pharmaceutics. 667(Pt B). 124880–124880.
3.
Loryan, Irena, Andreas Reichel, Bo Feng, et al.. (2022). Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development. Pharmaceutical Research. 39(7). 1321–1341. 62 indexed citations
4.
5.
Hamm, Grégory, Anna Nilsson, Nicole Strittmatter, et al.. (2019). Revealing the Regional Localization and Differential Lung Retention of Inhaled Compounds by Mass Spectrometry Imaging. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 33(1). 43–53. 16 indexed citations
6.
Hu, Yang, Margareta Hammarlund‐Udenaes, & Markus Fridén. (2019). Understanding the Influence of Nanocarrier-Mediated Brain Delivery on Therapeutic Performance Through Pharmacokinetic-Pharmacodynamic Modeling. Journal of Pharmaceutical Sciences. 108(10). 3425–3433. 7 indexed citations
7.
Colclough, Nicola, Kan Chen, Peter Johnström, Markus Fridén, & Dermot F. McGinnity. (2019). Building on the success of osimertinib: achieving CNS exposure in oncology drug discovery. Drug Discovery Today. 24(5). 1067–1073. 22 indexed citations
8.
Schou, Magnus, Pär Ewing, Zsolt Cselényi, et al.. (2019). Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator. EJNMMI Research. 9(1). 9–9. 9 indexed citations
9.
Fridén, Markus, et al.. (2018). Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(1). 1–12. 38 indexed citations
10.
Fridén, Markus, et al.. (2017). Benchmarking of Human Dose Prediction for Inhaled Medicines from Preclinical In Vivo Data. Pharmaceutical Research. 34(12). 2557–2567. 12 indexed citations
11.
Lindqvist, Annika, Markus Fridén, & Margareta Hammarlund‐Udenaes. (2016). Pharmacokinetic considerations of nanodelivery to the brain: Using modeling and simulations to predict the outcome of liposomal formulations. European Journal of Pharmaceutical Sciences. 92. 173–182. 23 indexed citations
12.
Ewing, Pär, et al.. (2015). A Novel In Vivo Receptor Occupancy Methodology for the Glucocorticoid Receptor: Toward An Improved Understanding of Lung Pharmacokinetic/Pharmacodynamic Relationships. Journal of Pharmacology and Experimental Therapeutics. 353(2). 279–287. 14 indexed citations
13.
Lundqvist, Anders, et al.. (2015). Development of a Novel Lung Slice Methodology for Profiling of Inhaled Compounds. Journal of Pharmaceutical Sciences. 105(2). 838–845. 37 indexed citations
14.
Varadharajan, Srinidhi, Susanne Winiwarter, Lars Carlsson, et al.. (2014). Exploring In Silico Prediction of the Unbound Brain-to-Plasma Drug Concentration Ratio: Model Validation, Renewal, and Interpretation. Journal of Pharmaceutical Sciences. 104(3). 1197–1206. 39 indexed citations
15.
Sällström, Johan & Markus Fridén. (2013). Simultaneous determination of renal plasma flow and glomerular filtration rate in conscious mice using dual bolus injection. Journal of Pharmacological and Toxicological Methods. 67(3). 187–193. 14 indexed citations
16.
Fridén, Markus, Fredrik Bergström, Hong Wan, et al.. (2010). Measurement of Unbound Drug Exposure in Brain: Modeling of pH Partitioning Explains Diverging Results between the Brain Slice and Brain Homogenate Methods. Drug Metabolism and Disposition. 39(3). 353–362. 129 indexed citations
17.
Fridén, Markus, et al.. (2009). Development of a High-Throughput Brain Slice Method for Studying Drug Distribution in the Central Nervous System. Drug Metabolism and Disposition. 37(6). 1226–1233. 87 indexed citations
18.
Sällström, Johan, et al.. (2008). C-Peptide Normalizes Glomerular Filtration Rate in Hyperfiltrating Conscious Diabetic Rats. Advances in experimental medicine and biology. 645. 219–225. 14 indexed citations
19.
Hammarlund‐Udenaes, Margareta, Markus Fridén, Stina Syvänen, & Anubha Gupta. (2007). On The Rate and Extent of Drug Delivery to the Brain. Pharmaceutical Research. 25(8). 1737–1750. 373 indexed citations
20.
Fridén, Markus, et al.. (2007). In Vitro Methods for Estimating Unbound Drug Concentrations in the Brain Interstitial and Intracellular Fluids. Drug Metabolism and Disposition. 35(9). 1711–1719. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Reichel Breakdown of academic impact, for papers by Bill J. Smith Breakdown of academic impact, for papers by Tristan S. Maurer Breakdown of academic impact, for papers by Ulf Bredberg Breakdown of academic impact, for papers by J. Cory Kalvass Breakdown of academic impact, for papers by Michel Lemaire Breakdown of academic impact, for papers by Italo Poggesi Breakdown of academic impact, for papers by Yanping Sun Breakdown of academic impact, for papers by Takashi Kuwabara Breakdown of academic impact, for papers by Bo Feng
Rankless by CCL
2026